PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases
Modern Pathology · 2024-02 · 37 (2) · 100387
DOI: 10.1016/j.modpat.2023.100387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2024-02. Verfasst von Sabrina Rossi und 36 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Electronic address: sabrina2.rossi@opbg.net. Hauptthemen laut MEDLINE: Chromothripsis, Sarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Ministry of Health.
Abstract (Originalsprache)
PATZ1-rearranged sarcomas are well-recognized tumors as part of the family of round cell sarcoma with EWSR1-non-ETS fusions. Whether PATZ1-rearranged central nervous system (CNS) tumors are a distinct tumor type is debatable. We thoroughly characterized a pediatric series of PATZ1-rearranged CNS tumors by chromosome microarray analysis (CMA), DNA methylation analysis, gene expression profiling and, when frozen tissue is available, optical genome mapping (OGM). The series consisted of 7 cases (M:F=1.3:1, 1-17 years, median 12). On MRI, the tumors were supratentorial in close relation to the lateral ventricles (intraventricular or iuxtaventricular), preferentially located in the occipital lobe. Two major histologic groups were identified: one (4 cases) with an overall glial appearance, indicated as "neuroepithelial" (NET) by analogy with the corresponding methylation class (MC); the other (3 cases) with a predominant spindle cell sarcoma morphology, indicated as "sarcomatous" (SM). A single distinct methylation cluster encompassing both groups was identified by multidimensional scaling analysis. Despite the epigenetic homogeneity, unsupervised clustering analysis of gene expression profiles revealed 2 distinct transcriptional subgroups correlating with the histologic phenotypes. Interestingly, genes implicated in epithelial-mesenchymal transition and extracellular matrix composition were enriched in the subgroup associated to the SM phenotype. The combined use of CMA and OGM enabled the identification of chromosome 22 chromothripsis in all cases suitable for the analyses, explaining the physical association of PATZ1 to EWSR1 or MN1. Six patients are currently disease-free (median follow-up 30 months, range 12-92). One patient of the SM group developed spinal metastases at 26 months from diagnosis and is currently receiving multimodal therapy (42 months). Our data suggest that PATZ1-CNS tumors are defined by chromosome 22 chromothripsis as causative of PATZ1 fusion, show peculiar MRI features (eg, relation to lateral ventricles, supratentorial frequently posterior site), and, although epigenetically homogenous, encompass 2 distinct histologic and transcriptional subgroups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Electronic address: sabrina2.rossi@opbg.net.
- Pathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Imaging Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy; Department of Neuroscience, Imaging and Clinical Sciences (DNISC), University "Gabriele D'Annunzio" of Chieti-Pescara, Chieti, Italy.
- Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Multimodal Research Area, Unit of Microbiology and Diagnostics in Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Förderung
- Ministry of Health
Zitieren
APA
Rossi, S., Barresi, S., Colafati, G. S., Genovese, S., Tancredi, C., Costabile, V., Patrizi, S., Giovannoni, I., Asioli, S., Poliani, P. L., Gardiman, M. P., Cardoni, A., Del Baldo, G., Antonelli, M., Gianno, F., Piccirilli, E., Catino, G., Martucci, L., Quacquarini, D., …, & Alaggio, R. (2024). PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases. Modern Pathology, 37(2), 100387. https://doi.org/10.1016/j.modpat.2023.100387
Vancouver
Rossi S, Barresi S, Colafati GS, Genovese S, Tancredi C, Costabile V, et al. PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases. Modern Pathology. 2024;37(2):100387. doi:10.1016/j.modpat.2023.100387
BibTeX
@article{Rossi2024,
author = {Rossi, Sabrina and Barresi, Sabina and Colafati, Giovanna Stefania and Genovese, Silvia and Tancredi, Chantal and Costabile, Valentino and Patrizi, Sara and Giovannoni, Isabella and Asioli, Sofia and Poliani, Pietro Luigi and Gardiman, Marina Paola and Cardoni, Antonello and Del Baldo, Giada and Antonelli, Manila and Gianno, Francesca and Piccirilli, Eleonora and Catino, Giorgia and Martucci, Licia and Quacquarini, Denise and Toni, Francesco and Melchionda, Fraia and Viscardi, Elisabetta and Zucchelli, Mino and Dal Pos, Sandro and Gatti, Enza and Liserre, Roberto and Schiavello, Elisabetta and Diomedi-Camassei, Francesca and Carai, Andrea and Mastronuzzi, Angela and Gessi, Marco and Giannini, Caterina and Novelli, Antonio and Onetti Muda, Andrea and Miele, Evelina and Alesi, Viola and Alaggio, Rita},
title = {PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases},
journal = {Modern Pathology},
year = {2024},
volume = {37},
number = {2},
pages = {100387},
doi = {10.1016/j.modpat.2023.100387}
}
EUVIMED